Clinical utility and development of biomarkers in invasive aspergillosis.

Pharmacology, Toxicology and Pharmaceutical Science

• Invasive Aspergillosis 100%
• Animal 66%
• Organisms 50%
• Aspergillus 50%
• Aspergillosis 33%
• Infection 33%
• Diseases 16%
• Biological Marker 16%
• Antigen 16%
• Microorganism 16%
• Glucan 16%
• DNA 16%
• Galactomannan 16%
• Enalapril Maleate 16%
• Virulence 16%
• Allergy 16%
• Pathogenicity 16%

Biochemistry, Genetics and Molecular Biology

• Animal Models 66%
• Organisms 50%
• Development 33%
• Polymerase Chain Reaction 33%
• Proteomics 16%
• Virulence 16%
• Galactomannan 16%
• Exercise 16%
• Glucan 16%
• Genetic Manipulation 16%
• Motivation 16%
• Health 16%
• Flow 16%
• DNA 16%

Immunology and Microbiology

• Aspergillus 83%
• Organisms 50%
• Development 33%
• Microorganism 16%
• Antigen 16%
• Virulence 16%
• Pathogenicity 16%
• Allergy 16%
• Genetic Manipulation 16%
• Exercise 16%
• Health 16%
• Flow 16%